Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma
Condition(s):Duodenal CancerLast Updated:November 26, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Duodenal CancerLast Updated:November 26, 2021Completed
Condition(s):Third-line Treatment; Dvanced Duodenal Adenocarcinoma; Furquinelone Combined With SintilimabLast Updated:April 12, 2023Not yet recruiting
Condition(s):ERCPLast Updated:May 11, 2020Completed
Condition(s):Familial Adenomatous PolyposisLast Updated:January 14, 2016Unknown status
Condition(s):Adenocarcinoma of the Pancreas; Adenocarcinoma of the Duodenum; Ampullary AdenocarcinomaLast Updated:March 17, 2022Recruiting
Condition(s):Early Gastric Cancer; Barrett EsophagusLast Updated:February 15, 2024Completed
Condition(s):Adenocarcinoma of Head of Pancreas; Cholangio Carcinoma; Duodenal Adenocarcinoma; Carcinoma of Ampulla of VaterLast Updated:September 15, 2015Completed
Condition(s):Pancreas Cancer; Surgery-Complications; Biliary FistulaLast Updated:June 28, 2022Completed
Condition(s):Pancreatic Adenocarcinoma; Pancreatic Cysts; Pancreatic Endocrine Tumors; Chronic Pancreatitis; Cholangiocarcinoma, Extrahepatic; Ampullary Adenocarcinoma; Duodenal AdenocarcinomaLast Updated:May 3, 2022Recruiting
Condition(s):Acinar Cell Carcinoma; Ampulla of Vater Adenocarcinoma; Cholangiocarcinoma; Duodenal Adenocarcinoma; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraductal Papillary Mucinous Neoplasm; Periampullary AdenocarcinomaLast Updated:January 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.